Previous close | 20.00 |
Open | 19.06 |
Bid | 16.80 |
Ask | 17.30 |
Strike | 130.00 |
Expiry date | 2024-10-18 |
Day's range | 19.06 - 20.00 |
Contract range | N/A |
Volume | |
Open interest | 203 |
BD (BDX) announces the commercial launch of its new single-cell research tool, BD Rhapsody ATAC-Seq Assay, to help researchers understand DNA regulation.
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.
Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform Mako and its broad product portfolio.